Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients

NCT05926518 · clinicaltrials.gov ↗

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Critical Illness
Therapeutic Drug Monitoring
Venous Thromboembolism

Interventions

PROCEDURE: blood sampling

Sponsor

Rijnstate Hospital